Chemical carcinogens increase tumor incidence and cancer, often by direct interactions with DNA as DNA damage and genomic mutations are key factors in mutagenesis. There are several mechanisms underlying chemical carcinogenesis. Alkylating agents have electrophilic centers that enable the covalent addition of methyl or ethyl groups to the N7 atom of guanosine. Aromatic moieties of aralkylating agents can form adducts with DNA. Some chemicals become carcinogenic only after being metabolized by cytochrome P450 enzymes. Some carcinogens do not cause DNA damage directly but induce the intracellular production of reactive oxygen species such as peroxide (H2/O2), superoxide anion (O2) and peroxynitrite (ONOO), that may result in gene mutations. Polymerases may misread altered DNA, inducing point mutations. Alternatively, the presence of adducts or other modifications may increase the incidence of chromosomal breakage and rearrangement. When DNA repair mechanisms fail, these mutations, deletions, and rearrangements become part of the somatic cell genome that is replicated during cell division. The transformation of a normal cell to a cancerous cell can occur when a mutated or translocated oncogene or tumor suppressor gene is expressed. A mutated gene may produce no protein or a mutant protein with altered function. Alternatively, a normally silent gene may become dissociated from its control sequences and be expressed constitutively. When these processes lead to cell immortalization and unchecked proliferation rather than to apoptosis or cellular senescence, tumorigenesis may result. Chemical carcinogens are often used to model tumorigenesis in animals or cultured cell lines. Researchers use these models not only to study the intervention of chemopreventive and therapeutic agents, but also to discover the mechanisms underlying cancer progression and metastasis.
| Carcinogens |
| Product # |
Product Name |
Application |
Add to Cart |
| 11,007-8 |
Acetaldehyde ReagentPlus, 99% |
Shown to induce adenocarcinomas and squamous-cell carcinomas of the nasal mucosa in rats and laryngeal carcinomas in hamsters. Inhalation of acetaldehyde enhances the incidence of respiratory-tract tumors produced by intratracheal instillation of benzo[a] |
|
| 32,013-7 |
Acrylonitrile ≥99% |
Induces lung and prostate cancer. |
|
| A6636 |
Aflatoxin B1 from Aspergillus flavus |
Hepatocarcinogen; food contaminant produced by Aspergillus flavus, a common soil fungus. |
|
| A9887 |
Aflatoxin B2 |
Hepatocarcinogen; food contaminant produced by Aspergillus flavus, a common soil fungus. |
|
| A0138 |
Aflatoxin G1 from Aspergillus flavus |
Hepatocarcinogen; food contaminant produced by Aspergillus flavus, a common soil fungus. |
|
| A0263 |
Aflatoxin G2 |
Hepatocarcinogen; food contaminant produced by Aspergillus flavus, a common soil fungus. |
|
| A6428 |
Aflatoxin M1 from Aspergillus flavus |
Hepatocarcinogen; food contaminant produced by Aspergillus flavus, a common soil fungus. |
|
| A9401 |
Aflatoxin M2 |
Hepatocarcinogen; food contaminant produced by Aspergillus flavus, a common soil fungus. |
|
| A5512 |
Aristolochic acid powder |
Linked to cancer of the urinary tract. |
|
| A1010 |
Arsenic(III) oxide ReagentPlus, ≥99.0% |
Very potent agent against acute promyelocytic leukemia (APL). Induces skin, lung, and bladder cancer. |
|
| A2853 |
Azoxymethane 13.4 M, ≥95% (GC), contains ≤25% ethanol (Packaged based on azoxymethane. ) |
Commonly used to induce aberrant crypt foci and colon cancer in mice and rats. |
|
| 27,070-9 |
Benzene CHROMASOLV Plus, for HPLC, ≥99.9% |
Linked to causing leukemia. Increased risk of total lymphatic and hematopoietic cancers. |
|
| B1760 |
Benzo[a]pyrene ≥96% (HPLC) |
Induces lung cancer in mice. Strong mutagen; requires metabolic activation. |
|
| 29,503-5 |
1,3-Butadiene ≥99% |
Environmental carcinogen. Induces cardiac hemangiosarcomas in mice. |
|
| C3141 |
Cadmium chloride Hemi(pentahydrate) ≥98% (titration) |
Induces malignant tumor formation at various sites in multiple species of experimental animals. Inhalation exposure causes lung tumors (pulmonary adenocarcinoma) in rats. When administered orally to rats, causes dose-related increases in the incidences |
|
| 57,101-6 |
Carbon tetrachloride anhydrous, ≥99.5% |
Induces liver cancer in mice and rats. |
|
| D9886 |
3,3′-Dichlorobenzidine Dihydrochloride |
An important intermediate in the production of diarylide azo pigments and a known animal carcinogen. |
|
| D4628 |
Diethylstilbestrol ≥99% (HPLC) |
Induces renal clear-cell carcinoma in Syrian hamster. In humans it increases the risk of breast cancer, clear cell adenocarcinoma (CCA) of the vagina and cervix, and reproductive anomalies. Used in the treatment of prostate cancer to block the production |
|
| D3254 |
7,12-Dimethylbenz[a]anthracene ≥95% |
Used to induce colon, skin, and mammary tumors in mice. |
|
| D16,160-8 |
N,N-Dimethylhydrazine 98% |
Inducer of colon cancer in mice and rats. |
|
| D16,180-2 |
N,N′-Dimethylhydrazine Dihydrochloride ≥99% |
Induces colon cancer in mice and rats. |
|
| E1260 |
L-Ethionine ~99% (TLC) |
Inducer of differentiation in human promyelocytic leukemia cells (HL-60) |
|
| A7015 |
N-(2-Fluorenyl)acetamide ≥90% (TLC) |
Induces the development of tumors of the liver, bladder, renal pelvis, Zymbal gland, colon, lung, pancreas, and testis in rats. Induces tumors of the liver, bladder, and kidney in mice. |
|
| F1635 |
Formaldehyde Solution 37 wt. % in solution |
Induces tumors in the nasal epithelium of rats and is suspected to be a human carcinogen. |
|
| H3660 |
Hydroquinone meets USP testing |
Mice show an increased incidence of skin tumors. Increases in tubular cell adenomas of the kidney of male rats, and increases in mononuclear cell leukemia in female rats. |
|
| H9003 |
Hydroquinone ReagentPlus, ≥99% |
Mice show an increased incidence of skin tumors. Increases in tubular cell adenomas of the kidney of male rats, and increases in mononuclear cell leukemia in female rats. |
|
| 21,394-2 |
3-Methylcholanthrene (20) 98% |
Used to induce sarcomas and skin carcinomas in laboratory animals. |
|
| 12,994-1 |
1-Methyl-3-nitro-1-nitrosoguanidine 97% |
Environmental mutagen and carcinogen; used to induce gastric cancer in mice. |
|
| N8381 |
2-Naphthylamine powder |
Causes malignant bladder tumors in hamsters, dogs, and rhesus monkeys and liver tumors in mice; bladder tumors also observed in rats at a low incidence. 2-Naphthylamine causes genetic damage in test systems, including mutations in bacteria, yeast, insect |
|
| N3876 |
(−)-Nicotine ≥99% (GC), liquid |
Metabolism of nicotine forms byproducts that the lungs convert into potent carcinogens. |
|
| N5260 |
(−)-Nicotine Hydrogen tartrate salt ≥98% (TLC), powder |
Metabolism of nicotine forms byproducts that the lungs convert into potent carcinogens. |
|
| 45,652-7 |
6-Nitrochrysene 95% |
Potent lung and liver carcinogen in mice. |
|
| N2,295-9 |
1-Nitropyrene 99% |
Potent mutagen, carcinogen, environmental pollutant. |
|
| N0756 |
N-Nitrosodiethylamine |
Carcinogenic in all animal species tested. The main target organs are the nasal cavity, trachea, lung, esophagus, and liver. |
|
| N0258 |
N-Nitrosodiethylamine ISOPAC® |
Carcinogenic in all animal species tested. The main target organs are the nasal cavity, trachea, lung, esophagus, and liver. |
|
| N2,500-1 |
N-Nitrosodimethylamine reagent grade |
Induces gastric, liver, kidney, and lung cancer in mice and rats. |
|
| N3632 |
N-Nitrosodimethylamine ISOPAC® |
Induces gastric, liver, kidney, and lung cancer in mice and rats. |
|
| N8509 |
N-Nitroso-N-ethylurea |
Carcinogenic in many animal species. Induces benign and malignant tumors of numerous types, including the nervous tissue, stomach, esophagus, pancreas, respiratory tract, intestine, lymphoreticular tissues, skin, and kidney. |
|
| N3385 |
N-Nitroso-N-ethylurea ISOPAC® |
Carcinogenic in many animal species. Induces benign and malignant tumors of numerous types, including the nervous tissue, stomach, esophagus, pancreas, respiratory tract, intestine, lymphoreticular tissues, skin, and kidney. |
|
| N4766 |
N-Nitroso-N-methylurea |
Carcinogenic in many animal species. Induces benign and malignant tumors of numerous types, including the nervous tissue, stomach, esophagus, pancreas, respiratory tract, intestine, lymphoreticular tissues, skin, and kidney. |
|
| N1517 |
N-Nitroso-N-methylurea ISOPAC® |
Carcinogenic in many animal species. Induces benign and malignant tumors of numerous types, including the nervous tissue, stomach, esophagus, pancreas, respiratory tract, intestine, lymphoreticular tissues, skin, and kidney. |
|
| N6007 |
1-Nitrosopiperidine |
Produces benign and malignant tumors of the liver, lung, forestomach, and esophagus in mice; of the liver, esophagus, and respiratory system in rats; and of the upper digestive tract, respiratory system, and liver in hamsters. Produces hepatocellular carc |
|
| 15,824-0 |
1-Nitrosopyrrolidine 99% |
Induces hepatocellular carcinomas and lung adenomas in mice. |
|
| S9652 |
Safrole ≥97% |
Increases the incidence of liver cell tumors in mice. Increases liver hepatocellular carcinomas and cholangiocarcinomas in rats of both sexes and hepatocellular carcinomas in male mice. Through subcutaneous injection, induces lung adenomas and adenocarci |
|
| T750-0 |
Thiosalicylic acid ≥95% |
Animal carcinogen that produces increased incidence of renal adenomas, adenocarcinomas, mononuclear cell leukemia, and hepatocellular tumors. |
|
| T750-0 |
Tetrachloroethylene ReagentPlus, 99% |
Animal carcinogen that produces increased incidence of renal adenomas, adenocarcinomas, mononuclear cell leukemia, and hepatocellular tumors. |
|
| Back to top |